David Shaw’s Fresenius Medical Care FMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.76M | Sell |
210,747
-218,585
| -51% | -$4.91M | ﹤0.01% | 2448 |
|
|
2026
Q1 | $9.69M | Buy |
429,332
+396,336
| +1,201% | +$9.1M | 0.01% | 1668 |
|
|
2025
Q4 | $786K | Buy |
+32,996
| New | +$821K | ﹤0.01% | 3682 |
|
|
2024
Q4 | – | Sell |
-14,340
| Closed | -$305K | – | 4541 |
|
|
2024
Q3 | $305K | Buy |
+14,340
| New | +$282K | ﹤0.01% | 3966 |
|
|
2024
Q2 | – | Sell |
-76,176
| Closed | -$1.47M | – | 4598 |
|
|
2024
Q1 | $1.47M | Buy |
76,176
+60,831
| +396% | +$1.21M | ﹤0.01% | 2844 |
|
|
2023
Q4 | $320K | Buy |
+15,345
| New | +$295K | ﹤0.01% | 3722 |
|
|
2022
Q4 | – | Sell |
-120,069
| Closed | -$1.69M | – | 4933 |
|
|
2022
Q3 | $1.69M | Buy |
+120,069
| New | +$2.27M | ﹤0.01% | 3145 |
|
|
2022
Q2 | – | Sell |
-70,443
| Closed | -$2.37M | – | 5467 |
|
|
2022
Q1 | $2.37M | Sell |
70,443
-3,437
| -5% | -$113K | ﹤0.01% | 3146 |
|
|
2021
Q4 | $2.4M | Buy |
+73,880
| New | +$2.43M | ﹤0.01% | 3192 |
|
|
2021
Q2 | – | Sell |
-26,363
| Closed | -$972K | – | 4831 |
|
|
2021
Q1 | $972K | Sell |
26,363
-35,980
| -58% | -$1.36M | ﹤0.01% | 3135 |
|
|
2020
Q4 | $2.59M | Buy |
62,343
+55,152
| +767% | +$2.3M | ﹤0.01% | 2383 |
|
|
2020
Q3 | $305K | Buy |
+7,191
| New | +$310K | ﹤0.01% | 3440 |
|
|
2020
Q2 | – | Sell |
-40,229
| Closed | -$1.32M | – | 4065 |
|
|
2020
Q1 | $1.32M | Sell |
40,229
-36,176
| -47% | -$1.34M | ﹤0.01% | 2511 |
|
|
2019
Q4 | $2.81M | Buy |
76,405
+68,731
| +896% | +$2.44M | ﹤0.01% | 2196 |
|
|
2019
Q3 | $258K | Sell |
7,674
-5,510
| -42% | -$195K | ﹤0.01% | 3526 |
|
|
2019
Q2 | $518K | Sell |
13,184
-826
| -6% | -$32.7K | ﹤0.01% | 3060 |
|
|
2019
Q1 | $568K | Sell |
14,010
-197,754
| -93% | -$7.37M | ﹤0.01% | 2926 |
|
|
2018
Q4 | $6.86M | Buy |
211,764
+180,445
| +576% | +$7.28M | 0.01% | 1332 |
|
|
2018
Q3 | $1.61M | Buy |
+31,319
| New | +$1.57M | ﹤0.01% | 2353 |
|
|
2018
Q2 | – | Sell |
-28,136
| Closed | -$1.44M | – | 3753 |
|
|
2018
Q1 | $1.44M | Buy |
28,136
+10,963
| +64% | +$585K | ﹤0.01% | 2260 |
|
|
2017
Q4 | $902K | Sell |
17,173
-25,660
| -60% | -$1.27M | ﹤0.01% | 2637 |
|
|
2017
Q3 | $2.09M | Buy |
+42,833
| New | +$2.04M | ﹤0.01% | 1986 |
|
|
2017
Q2 | – | Sell |
-14,029
| Closed | -$591K | – | 3418 |
|
|
2017
Q1 | $591K | Sell |
14,029
-77,598
| -85% | -$3.21M | ﹤0.01% | 2642 |
|
|
2016
Q4 | $3.87M | Buy |
91,627
+86,000
| +1,528% | +$3.51M | 0.01% | 1501 |
|
|
2016
Q3 | $246K | Sell |
5,627
-59,467
| -91% | -$2.66M | ﹤0.01% | 3129 |
|
|
2016
Q2 | $2.84M | Sell |
65,094
-49,313
| -43% | -$2.13M | 0.01% | 1676 |
|
|
2016
Q1 | $5.04M | Buy |
114,407
+91,260
| +394% | +$3.86M | 0.01% | 1270 |
|
|
2015
Q4 | $968K | Sell |
23,147
-658
| -3% | -$27.7K | ﹤0.01% | 2650 |
|
|
2015
Q3 | $929K | Sell |
23,805
-10,618
| -31% | -$432K | ﹤0.01% | 2648 |
|
|
2015
Q2 | $1.43M | Sell |
34,423
-49,908
| -59% | -$2.13M | ﹤0.01% | 2444 |
|
|
2015
Q1 | $3.5M | Sell |
84,331
-61,877
| -42% | -$2.39M | 0.01% | 1626 |
|
|
2014
Q4 | $5.43M | Buy |
146,208
+687
| +0.5% | +$24.8K | 0.01% | 1510 |
|
|
2014
Q3 | $5.05M | Sell |
145,521
-32,083
| -18% | -$1.11M | 0.01% | 1561 |
|
|
2014
Q2 | $5.95M | Buy |
177,604
+84,229
| +90% | +$2.81M | 0.01% | 1486 |
|
|
2014
Q1 | $3.25M | Buy |
93,375
+1,324
| +1% | +$46.4K | ﹤0.01% | 1922 |
|
|
2013
Q4 | $3.27M | Sell |
92,051
-720
| -0.8% | -$24.1K | ﹤0.01% | 2049 |
|
|
2013
Q3 | $3M | Buy |
92,771
+14,138
| +18% | +$460K | ﹤0.01% | 2064 |
|
|
2013
Q2 | $2.77M | Buy |
+78,633
| New | +$2.73M | 0.01% | 1820 |
|
Other funds holding FMS
FMI
BIP
TAM
TRSOTSOK
David Shaw's FMS Position: Q2 2026 in Review
David Shaw reduced its Fresenius Medical Care (FMS) stake by 51% in Q2 2026, selling an estimated $4.91M and leaving 210,747 shares worth $4.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2448.
David Shaw first reported a position in FMS in Q2 2013 and has held it in 38 quarters since. The position peaked at $9.69M in Q1 2026. 232 funds tracked by Wall St. Rank hold FMS as of Q2 2026.
- David Shaw held 210,747 shares of Fresenius Medical Care worth $4.76M as of Q2 2026.
- David Shaw sold 218,585 Fresenius Medical Care shares in Q2 2026, an estimated $4.91M.
- Fresenius Medical Care made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2448 holding.
- David Shaw first reported a position in Fresenius Medical Care in Q2 2013 and has held it in 38 quarters since.
- David Shaw's Fresenius Medical Care position peaked at $9.69M in Q1 2026.
- 232 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.